ANNE-MARIE C JOHN ROSE-BROWN

Allopathic & Osteopathic Physicians|Family Medicine CLEARWATER, FL NPI 1013024850

General Payments — all program years on this page

$3,134.24

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 182
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $341.25 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $341.2514

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $210.507
Novo Nordisk AS $76.084
Acerta Pharma LLC $30.982
Bayer HealthCare Pharmaceuticals Inc. $23.691

By program year

Program yearAmountRecords
2018 $855.1057
2019 $1,111.6569
2020 $259.4315
2021 $35.432
2022 $103.186
2023 $428.2019
2024 $341.2514

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086132356 Bayer Healthcare Pharmaceuticals Inc. $23.69 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096597932 Novo Nordisk Inc $23.55 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096962446 Novo Nordisk Inc $20.15 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097256245 Novo Nordisk Inc $17.48 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097353335 Novo Nordisk Inc $14.90 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103999555 ABBVIE INC. $21.06 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103999557 ABBVIE INC. $30.92 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103999559 ABBVIE INC. $16.52 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103999561 ABBVIE INC. $13.62 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103999563 ABBVIE INC. $15.50 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103999565 ABBVIE INC. $32.75 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103999567 ABBVIE INC. $80.13 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104377351 AstraZeneca Pharmaceuticals LP $17.29 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105505552 AstraZeneca Pharmaceuticals LP $13.69 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.